CClinicalTrials.gg
CompletedNCT07717593Tactile SenseUpdated Jul 21, 2026

Assessment Tactile Sensory Function

An observational study in Tactile Sensation Values, sponsored by Istanbul Arel University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Istanbul Arel University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
121
Ages
18 Years to 25 Years
Sex
All
01

Study summary

A total of 121 healthy volunteers (96 females, 25 males; mean age: 20,75±2,20 years) participated in this cross-sectional study conducted in the Physiotherapy and Rehabilitation Laboratory of Istanbul Arel University. Tactile sensation was assessed using the Baseline 5-piece monofilament kit in 10 specific regions of both the dominant and non-dominant lower extremities. Measurements included the tip of the hallux, medial and lateral aspects of the leg, anterior and posterior thigh, and metatarsal regions. Data were analyzed using descriptive statistics. Between-group comparisons were made using the Mann-Whitney U test. Correlations between age, body mass index (BMI), and sensation values were analyzed using Spearman's correlation coefficient.

02

Conditions studied

  • Tactile Sensation Values
03

In context

Lead sponsor

Istanbul Arel University is the lead sponsor of 44 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

8-25 years healthy young adults university students.excluded if they had a history of lower limb injuries, systemic or neurological conditions, chronic pain, or skin-related issues potentially influencing tactile sensitivity, such as burns, calluses, scars, or tattoos.

Eligibility criteria

Inclusion Criteria: 18-25 years healthy young adults -

Exclusion Criteria: if they had a history of lower limb injuries, systemic or neurological conditions, chronic pain, or skin-related issues potentially influencing tactile sensitivity, such as burns, calluses, scars, or tattoos.

-

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
121 participants (actual)
Patient registry
No

Groups and cohorts

  • Young adults

    Young adults

    Other: Tactile sensation assesment by monofilament test kit

Interventions

  • OtherTactile sensation assesment by monofilament test kit

    The tactile sensibility of 10 predefined regions of the lower extremity was then evaluated using the Baseline brand tactile monofilament test kit, and the results were recorded. Before starting the procedure, each participant was properly positioned on an examination table first in the supine position and then in the prone position. During the assessment, the lower extremity was placed parallel to the ground. Once the participant was in a comfortable position, they were asked to close their eyes. The same examiner performed all the measurements. To minimize measurement bias, all tests were conducted by the same trained examiner under standardized environmental and procedural conditions. However, the use of a single examiner may limit inter-rater generalizability The monofilament test was applied three times to each predetermined region. Pressure was applied until the monofilament was gentlyently bent. Participants were instructed to say "yes" as soon as they perceived the stimulus, at

06

What researchers measure

Primary outcomes

  1. Tactile Sensation normative values

    The tactile sensibility of 10 predefined regions of the lower extremity was then evaluated using the Baseline brand tactile monofilament test kit, and the results were recorded. Before starting the procedure, each participant was properly positioned on an examination table first in the supine position and then in the prone position. During the assessment, the lower extremity was placed parallel to the ground. Once the participant was in a comfortable position, they were asked to close their eyes. The same examiner performed all the measurements. To minimize measurement bias, all tests were conducted by the same trained examiner under standardized environmental and procedural conditions. However, the use of a single examiner may limit inter-rater generalizability.The monofilament test was applied three times to each predetermined region. Pressure was applied until the monofilament was gentlyently bent. Participants were instructed to say "yes" as soon as they perceived the stimulus, at

    Time frame: june 2022-January 2023

  2. the normative data of the monofilament test of the lower extremity in the healthy, young Turkish population.

    the normative data of the monofilament test of the lower extremity in the healthy, young Turkish population.

    Time frame: 01 June 2022- 15 Jan 2023

Secondary outcomes

  1. Gender

    The secondary outcome was to make a comparison according to gender and laterality, whether through the dominant or non-dominant sides. Before the assessment, the laboratory environment was inspected to ensure suitability.

    Time frame: June 2022-January 2023

07

Study locations

1 site
  • Istanbul Arel University
    Istanbul, 34280, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07717593
Lead sponsor
Istanbul Arel University
Responsible party
Secil OZKURT (Assist Prof. Dr, Istanbul Arel University) — Principal investigator
First posted
Jul 21, 2026
Start date
Jun 1, 2022
Primary completion
Jan 15, 2023
Completion
Jan 20, 2023
Last update
Jul 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion